Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System

Clinical trial NCT04521569 · COMPLETED

Trial details

NCT number: NCT04521569
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lung Transplant

Start date: 2020-06-22
Primary completion: 2024-06-23
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.